KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $1.3 million.

  • Medpace Holdings' Change in Account Payables rose 198281.25% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 million, marking a year-over-year increase of 18866.78%. This contributed to the annual value of $2.6 million for FY2025, which is 18866.78% up from last year.
  • Per Medpace Holdings' latest filing, its Change in Account Payables stood at $1.3 million for Q4 2025, which was up 198281.25% from -$10.7 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Change in Account Payables peaked at $10.7 million during Q1 2025, and registered a low of -$10.7 million during Q3 2025.
  • Its 5-year average for Change in Account Payables is $450600.0, with a median of $682500.0 in 2024.
  • As far as peak fluctuations go, Medpace Holdings' Change in Account Payables surged by 209330.99% in 2022, and later tumbled by 176197.92% in 2025.
  • Over the past 5 years, Medpace Holdings' Change in Account Payables (Quarter) stood at -$284000.0 in 2021, then skyrocketed by 2093.31% to $5.7 million in 2022, then tumbled by 65.17% to $2.0 million in 2023, then crashed by 96.75% to $64000.0 in 2024, then surged by 1982.81% to $1.3 million in 2025.
  • Its Change in Account Payables stands at $1.3 million for Q4 2025, versus -$10.7 million for Q3 2025 and $1.3 million for Q2 2025.